Paul Mintz - 01 Aug 2025 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
Director
Signature
/s/ David Jorden, attorney-in-fact
Issuer symbol
AURX
Transactions as of
01 Aug 2025
Net transactions value
-$0.1
Form type
4
Filing time
04 Aug 2025, 09:13:40 UTC
Previous filing
22 Jul 2024
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mintz Paul Director C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON /s/ David Jorden, attorney-in-fact 04 Aug 2025 0001480208

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURX Common Stock Options Exercise $35,000 +87,500 $0.4000 87,500 01 Aug 2025 Direct
transaction AURX Common Stock Tax liability $35,000 -20,115 -23% $1.74 67,385 01 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURX Option to purchase common stock Options Exercise $0 -87,500 -100% $0.000000 0 09 Aug 2018 Common Stock 87,500 $0.4000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a net exercise of outstanding stock options. The reporting person received 67,385 shares of common stock on the net exercise of option to purchase 87,500 shares of common stock. The issuer withheld 20,115 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74.